This puts Spark in the vanguard of gene and cell therapy, and if approved by the FDA, it will be the first ever gene therapy for a genetic disease to reach the US market.

However, the lack of a clear timeline ... with its ctLNP (cell-targeted lipid nanoparticle) platform. Recent presentations at the European Society of Gene and Cell Therapy (ESGCT) and the American ...

From reprogrammed stem cells to next-generation ... and flexible editor may help us replace these disease-causing genetic sequences entirely.” Gene Therapy Allows a Deaf Child to Hear For ...

Global Scientific Director, Flow Cytometry and Targeted Cell Isolation, Labcorp Watch the second of a three-part roundtable series that focus on approaches to accelerating your advanced therapy ...